Biotech · Private company · Pittsburgh, PA, US
KaliVir Immunotherapeutics
Track this companyFree. Adds KaliVir Immunotherapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AtezolizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- VET3-TGIPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of VET3-TGI in Patients With Solid TumorsPHASE1 · RECRUITING · started Sep 16, 2024ClinicalTrials.gov NCT06444815 · fetched Nov 12, 2026
NIH awards1
- Translation of the novel oncolytic immunotherapy VET6-PDIFiscal year 2026 · $306.8KNIH RePORTER 1R44CA314562-01 · fetched Nov 12, 2026